Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy
Heart, ISSN: 1468-201X, Vol: 102, Issue: 10, Page: 741-747
2016
- 102Citations
- 88Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations102
- Citation Indexes102
- 102
- CrossRef48
- Captures88
- Readers88
- 88
Article Description
Objective: We hypothesised that abnormal global longitudinal strain (GLS) would predict outcome in hypertrophic cardiomyopathy (HCM) better than current echocardiographic measures. Methods: Retrospective analysis of risk markers in relation to outcomes in 472 patients with HCM at a single tertiary institution (2006-2012). Exclusion criteria were left ventricular (LV) hypertrophy of other origin, patients in atrial fibrillation, lost to follow-up and insufficient image quality to perform strain analysis. Standardised echocardiogram recordings were reviewed and standard variables and LV GLS were measured. The primary end-point included all cardiac deaths, appropriate defibrillator shocks and heart failure (HF) admissions. The secondary end-point was death by HF and admissions related to HF. Results: Mean age was 50.0±15.0 years; 322 (68%) were men. At a median of 4.3 years (IQR 0.1-7.8) follow-up, 21 (4.4%) patients experienced cardiovascular death: 6 (1.3%) died from HF, 13 (2.7%) had sudden cardiac death and 2 (0.4%) died secondary to stroke. Four (0.8%) patients experienced appropriate defibrillator shock, and 13 (2.7%) were admitted for HF. On multivariate Fine-Gray proportional hazard analyses, GLS was significantly associated with the primary endpoint (HR=0.90, 95% CI 0.83 to 0.98, p=0.018) independently of age, maximal provoked LV outflow-tract gradient and LV end-systolic volume. Moreover, GLS was particularly associated with the secondary end-point (HR=0.82, 95% CI 0.75 to 0.90, p<0.0001) independently of age, previous atrial fibrillation, New York Heart Association (NYHA) class III-IV, LV end-systolic volume, E/E′, and outflow-tract gradient. Survival curves confirmed that GLS was associated with HF events (GLS <15.6%, p=0.0035). Conclusions: In patients with HCM, reduced GLS is an independent factor associated with poor cardiac outcomes, and particularly HF outcomes.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84958093088&origin=inward; http://dx.doi.org/10.1136/heartjnl-2015-308576; http://www.ncbi.nlm.nih.gov/pubmed/26857213; https://heart.bmj.com/lookup/doi/10.1136/heartjnl-2015-308576; https://dx.doi.org/10.1136/heartjnl-2015-308576; https://heart.bmj.com/content/102/10/741; https://heart.bmj.com/content/102/10/741.abstract; https://heart.bmj.com/content/heartjnl/102/10/741.full.pdf; http://heart.bmj.com/content/102/10/741.full.pdf; https://heart.bmj.com/content/102/10/741.full.pdf; https://heart.bmj.com/content/102/10/741.full; http://heart.bmj.com/content/102/10/741.long; https://heart.bmj.com/content/102/10/741.long; http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2015-308576; http://heart.bmj.com/content/102/10/741.full; http://heart.bmj.com/content/102/10/741.short; http://heart.bmj.com/content/102/10/741.abstract; https://heart.bmj.com/content/102/10/741.short; http://heart.bmj.com/content/102/10/741
BMJ
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know